Showing results (271-280 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|August 13, 2011
RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitorsS E Martin, Z-H Wu, K Gehlhaus, et al.Current Cancer Drug Targets|July 19, 2011
Androgen receptor cofactors in prostate cancer: potential therapeutic targets of castration-resistant prostate cancerMasaki Shiota, Akira Yokomizo, Naohiro Fujimoto, et al.Current Cancer Drug Targets|December 15, 2011
Knockdown of insulin-like growth factor I receptor inhibits the growth and enhances chemo-sensitivity of liver cancer cellsY-W Zhang, D-L Yan, W Wang, et al.Current Cancer Drug Targets|December 15, 2011
Characterization of the prostaglandin E2 pathway in a rat model of esophageal adenocarcinomaE Piazuelo, S Santander, C Cebrián, et al.Current Cancer Drug Targets|December 15, 2011
Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancerS Tan, E G E de Vries, A G J van der Zee, et al.Current Cancer Drug Targets|March 15, 2012
Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinomaX Liu, J Lu, M-L He, et al.Current Cancer Drug Targets|March 6, 2012
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatmentS Solier, Y-W Zhang, A Ballestrero, et al.Current Cancer Drug Targets|March 6, 2012
Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamicsE Stec-Martyna, M Ponassi, M Miele, et al.Current Cancer Drug Targets|April 3, 2012
Pioglitazone prevents smoking carcinogen-induced lung tumor development in miceM-Y Li, A W Y Kong, H Yuan, et al.Current Cancer Drug Targets|October 18, 2011
Clinical experience with antiangiogenic therapy in leukemiaJ Wellbrock, W FiedlerPageof 187